Latest filing published 05 Nov 2024 for CalciMedica, Inc., €3,021.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -12.6%Entry US$17.50 · Close at T+365 US$15.30
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Sanderling Venture Partners VI Co Investment Fund LP: trading record in brief
Sanderling Venture Partners VI Co Investment Fund LP has filed trades across 2 companies (mainly through SEC (Form 4)), most often in CalciMedica, Inc. and Chimerix Inc. Over a trading history stretching from 5 September 2014 to 1 November 2024, the count stands at 4 filings.
Market trades split into 2 purchases (€302k) and 2 sales (€1.9M). Sales outweigh purchases by €1.6M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2024: 2 purchases and no sales on the market.
The latest filing, published on 5 November 2024, reports an open-market purchase of €3,021 in CalciMedica, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sanderling Venture Partners VI Co Investment Fund LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 877 shares@ US$3.751.0% of flowCommon StockSEC:0001415889-24-026103:1Canonical exit: 30 Jan 2025 (T+90)
- 86,867 shares@ US$3.75100.0% of flowCommon StockSEC:0001415889-24-026103:0Canonical exit: 30 Jan 2025 (T+90)
2 of 2 declarations
